Stock Events

Syndax Pharmaceuticals (SNDX) Q3 2024 Earnings

1AugConfirmed
Q3 2023
Q4 2023
Q2 2024
Q3 2024
-1
-0.91
-0.82
-0.73

Details

Expected EPS
-0.910767
Actual EPS
-0.8
Surprise EPS
0.11
Surprise Percent
+12.16%

Description

Syndax Pharmaceuticals (SNDX) has reported earnings of -0.8 per share for Q3 2024.

0 Comments

Share your thoughts